Back to SI SB Investment Advisers (UK) Ltd.
DNA
Showing 1 of 8 quarters
Position history for SISB Investment Advisers (UK) Ltd.'s holdings in Ginkgo Bioworks Holdings, Inc.
As of its Q2 2024 13F, SB Investment Advisers (UK) held 24,429,191 shares of DNA, worth $8.2M. SB Investment Advisers (UK)'s 13F filings listed DNA from Q4 2022 to Q2 2024, 7 quarterly filings. DNA was 0.1% of SB Investment Advisers (UK)'s reported 13F portfolio.
Final Value
$0
Final Shares
0
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History